Karessa's first day of trading on First North
Today is the first trading day for Karessa (ticker code KARE) on Nasdaq Stockholm First North. Karessa is developing and commercialising the next generation of pharmaceutical products to treat erectile dysfunction. The market is worth around USD 4.3 billion and is about to undergo significant changes, opening up major opportunities for Karessa.Almost half of all men above the age of 40 suffer from some degree of erectile dysfunction, i.e. the inability to achieve and maintain an erection that is sufficient to enable sexual activity. Karessa aims to develop the next generation of products in